Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2 Urinary Bladder Neoplasms 1 Strabismus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pain 1 Ovarian Neoplasms 1 Obesity 1 Multiple Myeloma 1 Mucositis 1 Lung Neoplasms 1 Insulin Resistance 1 Infertility, Female 1 Infertility 1 Hyperphagia 1 Hyperglycemia 1 Febrile Neutropenia 1 Emergence Delirium 1

Interventions

Metformin 6 Pioglitazone 3 drospirenone and ethinyl estradiol combination 1 Sugars 1 Sodium-Glucose Transporter 2 Inhibitors 1 Sitagliptin Phosphate 1 Simvastatin 1 Leuprolide 1 Insulin Glargine 1 Insulin 1 Injections 1 Fenofibrate 1 Estrogens 1 DNA, Ribosomal 1 Continuous Positive Airway Pressure 1 Canagliflozin 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Insulin Resistance × Injections × Clear all

NCT02216799 2016-02-25

GLUCOSE-in-PN

King Faisal Specialist Hospital & Research Center

Phase 4 Completed

Hyperglycemia, Hyperphagia, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡